Titan Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2021	2020	2019	2018	2017
Net Income	-14.86	-24.18	-41.91	-22.64	-33.59
Depreciation & Amortization	0.7	0.28	0.03	0.03	0.02
Share-Based Compensation	4.04	1.1	1.65	1.57	1.56
Other Operating Activities	-26.49	21.96	-5.74	-20.36	12.92
Operating Cash Flow	-36.62	-0.85	-45.96	-41.4	-19.09
Capital Expenditures	-0.37	-0.28	0	0	-0
Other Investing Activities	-0.39	-0.32	-0.46	-0.42	-0.2
Investing Cash Flow	-0.76	-0.6	-0.46	-0.42	-0.2
Share Issuance / Repurchase	44.18	24.69	35.77	27.16	41.08
Debt Issued / Paid	0.03	1.41	-0.01	0	0
Financing Cash Flow	44.21	26.1	35.76	27.16	41.08
Net Cash Flow	6.84	24.66	-10.66	-14.66	21.79
Free Cash Flow	-36.99	-1.13	-45.96	-41.4	-19.09
Free Cash Flow Margin	-184.08%	-5.63%	-	-	-
Free Cash Flow Per Share	-0.33	-0.02	-1.50	-2.49	-2.42

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).